| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $39.4M | +316.0% |
| R&D Expense | $6.3M | +287.6% |
| SG&A Expense | $14.5M | +426.2% |
| Operating Income | -$35.6M | -1065.0% |
| Pre-tax Income | -$11.6M | +14.2% |
| Income Tax | -$215K | — |
| Net Income | -$11.4M | +36.3% |
| EPS (Basic) | -$0.05 | +16.7% |
| EPS (Diluted) | -$0.05 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $337.2M | — |
| Short-term Investments | $1.1M | — |
| Accounts Receivable | $4.7M | +161.9% |
| Current Assets | $352.4M | — |
| Total Assets | $367.0M | +22.1% |
| Current Liabilities | $15.9M | +427.6% |
| Total Liabilities | $27.3M | -0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.3M | -508.8% |
| Capital Expenditures | $8.5M | +537.8% |
| Investing Cash Flow | -$10.1M | +96.6% |
| Financing Cash Flow | $332.8M | +10.9% |
| Free Cash Flow | -$40.9M | -514.7% |
| +16.7% |
| Stockholders' Equity |
| $339.6M |
| +1365.6% |